Merck and BioMed X Institute Extend Collaboration to Continue Novel Research in Oncology and Autoimmunity
- Merck to support up to six additional research projects at the BioMed X Institute in Heidelberg within the next six years
- Merck to support up to six additional research projects at the BioMed X Institute in Heidelberg within the next six years
SIFI amplia la sua presenza nell'Europa orientale e nell'Asia settentrionale firmando un accordo commerciale pluriennale con Bausch Health Russia
RIGA, Lettonia, 13 maggio 2021 /PRNewswire/ -- I dati finanziari consolidati e provvisori del Gruppo "Grindeks" mostrano che nel primo trimestre del 2021 il Gruppo ha notevolmente aumentato il fatturato e i profitti. In questo periodo il fatturato del Gruppo "Grindeks" ha raggiunto 54,7 milioni di euro, pari a 11,4 milioni di euro, ovvero il 26% in più rispetto al primo trimestre del 2020. L'utile del Gruppo nel primo trimestre del 2021 è stato di 10,9 milioni di euro, pari a 10,2 milioni di euro...
LONDON, May 13, 2021 /PRNewswire/ -- Materia, a medical cannabis and wellness company focused on the European market, today announces that its wholly-owned subsidiary Materia Malta Operating Ltd. ("Materia Malta" or the "Company") has received its European Union Good Manufacturing Practices ("EU GMP") certification from the Malta Medicines Authority.
SEOUL, South Korea, May 12, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a molecular diagnostics company reported its financial results for the first quarter of 2021, with reports showing robust earnings. The biotechnology firm posted KRW 351.8 billion in consolidated revenue, a 330% increase compared to the same period last year and a record for the first quarter. Operating profit at KRW 193.9 billion, also up 388% on-year, reflecting steady growth in its sales of diagnostic tests.
2020 sustainability report highlights emissions reduction strategy and other initiatives
MONTREAL, May 11, 2021 /PRNewswire/ -- CellCarta, a global provider of precision medicine services, announced today the acquisition of Reveal Biosciences ("Reveal"), a San Diego California based computational pathology company offering cutting-edge artificial intelligence (AI)-based quantitative pathology and immunohistochemistry services to the biopharmaceutical industry. This acquisition further strengthens CellCarta's position as a leading provider of histopathology biomarker services and will...
SEOUL, South Korea, May 11, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a leading molecular diagnostics firm said its German subsidiary, Seegene Germany GmbH is taking part in the government's Back-to-School program called the "Lolli-Test," a starting point in returning our daily lives back to normalcy. Under the program, Seegene Germany GmbH will be supplying COVID-19 diagnostic tests to laboratories, in business with the federal government, worth up to 19.3 million Euros
SHANGHAI, May 7, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed the acquisitions of a Bayer manufacturing facility in Wuppertal, Germany, the Pfizer China ("Pfizer") manufacturing facilities in Hangzhou, China as well as CMAB Biopharma Group ("CMAB").
Il risultato sul sotto-trattamento con farmaci biologici in una ricerca realizzata da CliCon e presentata in un convegno organizzato dal Gruppo Italiano Biosimilari (IBG) e dal Gruppo Italiano per le MICI
Expanding portfolio of solutions and capabilities addressing growing need for curated scientific data and expertise to accelerate discovery
ProGIFT è una sperimentazione clinica multicentrica, a 3 bracci, randomizzata, in doppio cieco, condotta in Italia.
ROME, April 23, 2021 /PRNewswire/ -- Maire Tecnimont S.p.A. announces that its subsidiary NextChem has been awarded today a contract by Total Corbion PLA, a 50/50 joint venture between Total and Corbion, to carry out a Front-End Engineering Design for their 100,000 tons per annum Poly Lactic Acid (PLA) plant in Grandpuits, France.
SHANGHAI, April 23, 2021 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the New Drug Application (NDA) of serplulimab injection (HLX10), a novel anti-PD-1 monoclonal antibody (mAb), for the treatment of unresectable or metastatic microsatellite instability-high (MSI-H) solid tumors that fail to respond to the standard therapy, has been accepted by the National Medical Products Administration (NMPA) and proposed to be granted priority review. Serplulimab is potentially to ...
MOSCOW, CAIRO and BERLIN, April 22, 2021 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), Egypt's Minapharm, the regional leader in recombinant DNA technology, and its Berlin-based subsidiary, ProBioGen AG, announce the agreement to produce over 40 million doses per year of the world's first registered vaccine against COVID-19, Sputnik V.
SAKURA, Japan, April 22, 2021 /PRNewswire/ -- Tokiwa Phytochemical Co., Ltd. (hereinafter "Tokiwa"), Japan, is excited to announce the publication of a joint research project with the University of Tokyo on a proprietary extract of "Kaempferia parviflora" (SIRTMAX (R)), commonly known as black turmeric.
▪Second public procurement agreement after Italy's procurement deal worth EUR 89.3 million
